What is Ion Beam Applications S.A.?
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally.
0GZK · Verdict
Limited reward · moderate risk
0GZK's standout is balance sheet; growth and profitability weigh on the picture.
Based on 88% data coverage
0GZK · Verdict
Current ratio 1.38
Revenue -11.5% CAGR
-2% net margin · 16% ROE
-2% net margin
Below average
Model-based scoring. For information only — not financial advice.
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The company is listed on the LSE in UK, with a market capitalisation of 495.90M, and a P/E ratio of 1.3x.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.